Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,525,726
+$517,624 QoQ
Shares Held
14,011
+1.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#1,538
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 42%
Shared 58%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Broderick Brian C holds $42,167,593 across 9 Drug Manufacturers - General names. ABBV ranks #3 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
75,019 | $19,052,571 | |
| 2 | LLY |
ELI LILLY & Co
|
11,816 | $14,172,462 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
14,011 | $3,525,726 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,484 | $3,017,692 | |
| 5 | PFE |
Pfizer Inc
|
28,800 | $693,504 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
10,117 | $582,941 | |
| 7 | NVS |
Novartis AG
|
2,946 | $461,696 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,310 | $418,185 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,525,726 | 14,011 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,008,102 | 13,831 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,044,628 | 13,325 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,095,688 | 13,370 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,425,310 | 13,066 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $2,740,101 | 13,078 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $2,328,402 | 13,103 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,587,578 | 13,103 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $2,250,855 | 13,123 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,296,644 | 12,612 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,695,214 | 10,939 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,818,083 | 12,197 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,652,731 | 12,267 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,954,990 | 12,267 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,993,781 | 12,337 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,746,339 | 13,012 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,027,377 | 13,237 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $2,482,226 | 15,312 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $2,153,130 | 15,902 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,716,425 | 15,912 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,799,647 | 15,977 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,742,016 | 16,097 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,726,399 | 16,112 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,411,247 | 16,112 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $1,458,460 | 14,855 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $1,182,085 | 15,515 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||